Zolpidem tartrate
Zolpidem belongs to a group of medicines called benzodiazepine-like medicines.
ApoZolpin is a sleeping pill that, by affecting the brain, causes sleepiness. It is used for the short-term treatment of insomnia in adults, only when the disorder is severe, disrupts normal functioning, or causes extreme suffering in the patient.
Before starting ApoZolpin, discuss with your doctor or pharmacist if:
Before taking this medicine
If the treatment of sleep disorders is not effective after 7-14 days, it may indicate a mental or physical illness that needs to be examined.
Zolpidem should not be taken by patients with severe liver function disorders, as liver failure may cause the accumulation of toxic substances in the body, leading to brain function disorders (encephalopathy).
ApoZolpin should not be taken by children and adolescents under 18 years old.
Take the prescribed dose of the medicine directly before bedtime. Do not take another dose during the same night.
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
ApoZolpin may affect the action of other medicines and/or the occurrence of side effects.
When zolpidem is used with some of the following medicines, drowsiness and psychomotor disorders the next day, including impaired driving ability, may be increased:
No significant interactions have been observed when zolpidem is administered in combination with warfarin (to reduce blood clotting), digoxin (in the treatment of heart failure), or ranitidine (in case of stomach problems).
Concomitant use of ApoZolpin and opioids (strong painkillers, drugs used in substitution therapy, and some cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening. For this reason, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor has prescribed ApoZolpin with opioids, they should limit the dose and duration of concomitant treatment.
Tell your doctor about all opioid medicines you are taking and strictly follow your doctor's instructions. It may be helpful to inform friends or relatives so that they are aware of the above symptoms. If such symptoms occur, contact your doctor.
When zolpidem is used with antidepressants, including bupropion, desipramine, fluoxetine, sertraline, and venlafaxine, the patient may see things that are not there (visual hallucinations).
Do not drink alcohol while taking ApoZolpin, as it may increase the sedative effect of the medicine.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Taking zolpidem during pregnancy may be harmful to the fetus.
In some studies, an increased risk of cleft lip and palate ("harelip") has been observed.
After administration of zolpidem in the second and/or third trimester of pregnancy, decreased fetal movement and changes in fetal heart rate may occur.
ApoZolpin should not be taken during pregnancy, especially during the first three months of pregnancy. If, for important medical reasons, ApoZolpin is taken in late pregnancy or during childbirth, the baby may experience: low body temperature, floppy baby syndrome, difficulty breastfeeding, breathing problems, and may exhibit withdrawal symptoms, such as restlessness, tremors after birth due to physical dependence. In such cases, newborns must be closely monitored in the postpartum period.
Do not breastfeed while taking ApoZolpin, as zolpidem passes into human milk in small amounts.
ApoZolpin has a major impact on the ability to drive and operate machinery, such as "falling asleep at the wheel". The patient should be aware that the next day after taking ApoZolpin (like other sleeping pills):
To minimize the risk of the above events, it is recommended to maintain at least an 8-hour interval between taking zolpidem and driving, operating machinery, and working at heights.
Do not drink alcohol or psychoactive substances while taking ApoZolpin, as this may increase the above effects.
If you have been diagnosed with an intolerance to some sugars, consult your doctor before taking the medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per 10 mg tablet, which means the medicine is considered "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
ApoZolpin is taken orally.
Since ApoZolpin acts very quickly, it should be taken directly before bedtime or while lying down.
The recommended dose of ApoZolpin is 10 mg per 24 hours. Your doctor may prescribe a lower dose for some patients.
ApoZolpin should be taken:
The usual dose is 5 mg. Do not exceed the prescribed dose.
The usual initial dose is 5 mg. The doctor may decide to increase the dose to 10 mg if it is safe. ApoZolpin should not be taken in cases of severe liver function disorders. Special caution is required in elderly patients with liver function disorders.
Patients with a history of respiratory disorders(chronic respiratory failure)
A lower dose is recommended.
ApoZolpin is not intended for persons under 18 years old.
The treatment period should be as short as possible. It usually ranges from a few days to two weeks.
The maximum treatment period, including gradual discontinuation, is four weeks.
Your doctor will determine the appropriate treatment period for you, according to your individual needs. In some cases, it may be necessary to take ApoZolpin for more than 4 weeks.
If you (or someone else) have taken a large number of tablets at once, or if you suspect that a child has swallowed a tablet, contact the nearest hospital emergency department or your doctor immediately. Take the medicine package and any remaining tablets with you. It is recommended to go there with someone else. If an overdose occurs, the patient may become very sleepy, which can lead to coma or even death after large doses of the medicine. If zolpidem is taken with other medicines that act on the central nervous system (including alcohol), it may have serious consequences, which can also be fatal. In moderate cases, symptoms include: drowsiness, confusion, and fatigue, lethargy (drowsiness). In more severe cases, symptoms may include: lack of coordination (ataxia), decreased muscle tone (hypotonia), low blood pressure (hypotension), respiratory depression, cases of impaired consciousness up to coma, and more severe symptoms, including death.
If you do not take a dose of the medicine directly before bedtime, but remember during the night, you can take the missed dose of the medicine only if you still have 8 hours of uninterrupted sleep. If this is not possible, take the next dose of the medicine before bedtime the next night. Do not take a double dose to make up for the missed dose.
In case of doubts about taking the medicine, consult your doctor or pharmacist.
Treatment should be discontinued gradually, as the symptoms for which the patient was being treated may return more severely than before (rebound insomnia). It may also cause anxiety, restlessness, and mood changes. These symptoms will subside over time.
If you become physically dependent on ApoZolpin, sudden discontinuation of treatment will lead to side effects, such as headaches, muscle pain, anxiety, tension, restlessness, confusion, and drowsiness. In severe cases, other symptoms may occur, such as increased sensitivity to light, noise, and touch, a feeling that sounds are louder than usual, and painful sensitivity to acoustic stimuli, hallucinations, numbness, and tingling in the limbs, loss of sense of reality (feeling that the surroundings are unreal), depersonalization (feeling of loss of one's own identity), or seizures (sudden, convulsive movements or tremors). These symptoms may also occur between doses, especially if the dose is high.
In case of any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, ApoZolpin can cause side effects, although not everybody gets them.
Zolpidem's side effects, especially those related to the central nervous system, depend on the dose and are less severe if the medicine is taken directly before bedtime or going to sleep. These side effects are more likely to occur in elderly patients.
If you experience any of the following symptoms, stop taking ApoZolpin and contact your doctor or go to the nearest hospital emergency department immediately:
These side effects are severe, but their frequency is not known (cannot be estimated from available data). You need medical attention.
Tell your doctor or pharmacist if you experience or worsen any of the following side effects:
Common(may affect up to 1 in 10 people):
The risk of amnesia is higher at higher doses. If you ensure that you can have 8 hours of uninterrupted sleep, the risk of amnesia is reduced.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from available data)
If you experience any side effects, including any not listed in the leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products, Medical Devices, and Biocides,
Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of the medicine.
Keep the medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton, label, or bottle after EXP. The expiry date refers to the last day of the month stated.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Coated tablet.
White or almost white, oval, biconvex coated tablets, with the inscription "E" on one side and the inscription "80" with a dividing line between "8" and "0" on the other side. The tablet can be divided into equal doses.
ApoZolpin is available in blisters and HDPE bottles.
Blisters: 7, 8, 10, 14, 15, 20, 28, 30, 50, 56, 60, and 100 coated tablets.
HDPE bottles: 30, 100, 250, and 500 coated tablets.
Not all pack sizes may be marketed.
Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lokal 27
01-909 Warsaw
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000, Malta
Rua João de Deus, 19
2700-487, Amadora, Portugal
Czech Republic:
Zolpidem Aurovitas
Germany:
Zolpidem PUREN 10 mg film-coated tablets
Poland:
ApoZolpin
Spain:
Zolpidem Aurovitas 10 mg film-coated tablets EFG
Netherlands:
Zolpidem tartrate Aurobindo 10 mg, film-coated tablets
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.